Identifying patients at risk of heart attack during elective PCI
Official title: Ability of a Precision Medicine Approach to Identify Stable CAD Patients Undergoing Elective PCI Who Are at Risk of Peri-PCI Myocardial Infarction/Myocardial Injury: The ABCD-Gene Prospective Study
Run by University of Florida · NCT05332262 · Data updated 2026-11-12
This study is testing a new scoring system to see if it can help identify patients with stable heart disease who are at risk of having a heart attack during a specific heart procedure called PCI.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | University of Florida Academic / other |
| Locations | 1 site (Jacksonville, Florida) |
| Status | Recruiting |
| Started | May 23, 2022 |
| Main results expected | December 2026 |
| Study ends | August 2027 |
| Registry record updated | January 20, 2026 |
| Trial ID | NCT05332262 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older with stable coronary artery disease undergoing elective PCI who are negative for troponin before the procedure.
✕Probably not a fit
Patients currently experiencing a myocardial infarction or those on alternative antiplatelet therapies like prasugrel or ticagrelor will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to validate the ABCD-GENE score, a precision medicine tool that integrates genetic and clinical data, to identify patients with stable coronary artery disease (CAD) who are at risk of experiencing myocardial infarction or myocardial injury during elective percutaneous coronary intervention (PCI). The study will involve a prospective cohort of 500 patients undergoing elective PCI while being treated with clopidogrel. By assessing platelet reactivity and troponin levels, the researchers hope to stratify patients based on their risk and potentially improve treatment outcomes. The findings could lead to better management strategies for patients undergoing PCI.
Why it matters
Potential benefit: If successful, this study could help identify patients at high risk for complications during PCI, allowing for tailored antiplatelet therapy and improved patient outcomes.
How similar studies have gone: Other studies have shown promise in using genetic and clinical factors to predict thrombotic complications in PCI, but this specific approach with the ABCD-GENE score is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: 1. Stable CAD undergoing elective PCI; 2. Male or females, Age ≥ 18 years old; 3. Troponin negative before PCI\*; 4. Background of aspirin therapy; * If troponin is unknown before coronary angiography and no clinical signs of acute coronary syndrome is present, a troponin will not be collected as this is line with standard practice. Exclusion criteria: 1. Current presentation with myocardial infarction; 2. On treatment with prasugrel or ticagrelor; 3. Documented hypersensitivity to clopidogrel; 4. Use of an intravenous antiplatelet therapy (i.e., cangrelor or GPI) during PCI; 5. Unable to provide written informed consent.
Where it's running
-
University of Florida Jacksonville
Jacksonville, Florida, United States Recruiting
Study contacts
- Principal investigator: Francesco Franchi, MD — University of Florida College of Medicine Jacksonville
- Study coordinator: Francesco Franchi, MD
- Email: francesco.franchi@jax.ufl.edu
- Phone: 9042442060
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.